Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- Check3 days agoChange DetectedA dedicated Locations section was added with sites in California, Pennsylvania, and Rio Grande do Sul and the page revision updated to v3.3.3. The previous standalone California Locations, Pennsylvania Locations, and Rio Grande do Sul Locations sections as well as the HHS Vulnerability Disclosure link were removed (v3.3.2).SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, replacing the previous wording, and the revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the banner about government funding-related updates; study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedThe screenshots show only cosmetic layout and formatting differences, with no changes to the main study details or outcomes.SummaryDifference0.5%

- Check82 days agoChange DetectedMajor update: page now includes government funding status notice and updated operating details, plus a new version tag v3.2.0. Removed a specific condition (Mucopolysaccharidosis type 1) and the old version tag.SummaryDifference4%

- Check89 days agoChange DetectedMinor corrections: standardize the medical condition name capitalization and bump the revision to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.